TrialMedical oncology (Northwood, London, England)2006

Efficacy and safety results with the combination therapy of arsenic trioxide, dexamethasone, and ascorbic acid in multiple myeloma patients: a phase 2 trial.

Rony M Abou-Jawde et al.PubMed ↗Publisher ↗

No numbers read from the abstract.